FDA Approves Durvalumab for Muscle Invasive Bladder Cancer By Ogkologos - May 2, 2025 627 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the NIAGARA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma 2026 ESMO TAT Honorary Award Recipient Announced Longer RFS with Nivolumab Than with Ipilimumab Among Patients with Resected Stage IIIB-C or Stage IV Melanoma MOST POPULAR First Global Estimates of Cervical Cancer Attributable to HIV November 30, 2020 FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer September 14, 2022 EMA Recommends Granting a Marketing Authorisation for Tisotumab Vedotin February 14, 2025 Cancer Patient’s Appetite Increases And His Blood Pressure Lowers After A... September 24, 2019 Load more HOT NEWS ¿Los sobrevivientes del cáncer necesitan ser positivos todo el tiempo? Permitirse... 74 & 75-Year-Old Sweethearts Get Married In ICU In Wake Of... KRASG12D-Mutated NSCLC is Subtype with Distinct Co-mutations, a Colder Immune Microenvironment,... Dr Ian Walker on Smoking: ‘A political no-brainer’
